US Tech 100

19,139.60

0.68%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

INSM

Insmed (INSM)

Insmed Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INSM

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
07/10/2024	5:19PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
07/05/2024	8:00AM	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
07/03/2024	9:03AM	PR Newswire (US)	Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference	NASDAQ:INSM	Insmed Inc
06/27/2024	8:00AM	PR Newswire (US)	Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025	NASDAQ:INSM	Insmed Inc
06/13/2024	8:00AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
06/12/2024	4:21PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
06/07/2024	8:00AM	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
06/05/2024	4:23PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
06/05/2024	8:00AM	PR Newswire (US)	Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
06/04/2024	7:00AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
06/03/2024	4:33PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/30/2024	5:46PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
05/30/2024	5:45PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
05/30/2024	5:44PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
05/30/2024	5:43PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
05/30/2024	5:41PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INSM	Insmed Inc
05/30/2024	5:32PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
05/30/2024	4:15PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/30/2024	4:05PM	PR Newswire (US)	Insmed to Host Commercial Webinar on June 4, 2024	NASDAQ:INSM	Insmed Inc
05/30/2024	4:02PM	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:INSM	Insmed Inc
05/30/2024	8:00AM	PR Newswire (US)	Insmed Announces Pricing of $650 Million Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
05/28/2024	6:21PM	PR Newswire (US)	Insmed Announces Proposed $500 Million Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
05/28/2024	4:51PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/28/2024	4:49PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/28/2024	4:47PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/28/2024	4:46PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/28/2024	4:40PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/28/2024	4:14PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INSM	Insmed Inc
05/28/2024	6:30AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INSM	Insmed Inc
05/28/2024	6:30AM	PR Newswire (US)	Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis	NASDAQ:INSM	Insmed Inc